drugset / Trial / NCT06545630
Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver Metastases
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study is to explore the safety and efficacy of tumor antigen-sensitized DC vaccine in postoperative adjuvant treatment of R0 excision Colorectal Cancer Liver Metastases.
Timeline
- Start
- 2023-11-01
- Primary completion
- 2025-11
- Completion
- 2026-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tumor antigen-sensitized DC vaccine | Vaccine | — | Subcutaneous |